Jungle Ventures

Jungle Ventures is a Singapore-headquartered multi-stage regional investor with deep coverage across Southeast Asia and India, prioritizing early-stage participation in emerging areas including AI infrastructure. Check sizes of $5M to $25M and a stage focus on Series A through Series C place the firm in the institutional Series A and growth-stage market. Healthcare exposure includes digital health and tech-enabled care delivery, with explicit AI thematic positioning.

The firm’s natural fit is with SEA and Indian founders building category-leading tech-enabled health platforms with credible regional or international expansion potential. For healthcare founders specifically, the right profile is a team running a Series A-ready or Series B-ready company with strong revenue, retention, and unit economics in a digital health, care delivery, or health-IT category. Founders building deep clinical assets, biotech, or sub-Series-A early-stage technology are not the natural target.

Geographically, Jungle’s advantage is its dual SEA-India footprint, with deep coverage of both regions and the ability to help founders contemplate cross-border strategies. For founders contemplating SEA-India cross-border expansion, Jungle is among the most thoughtful regional partners. The firm’s connectivity to global Series B and Series C capital is a meaningful asset for category leaders. For pure US-market founders, the strategic logic is thinner.

The right entry path is via an existing portfolio founder, a Series A co-investor, or an investment banker leading the round. The firm reads partner-led decks and moves at institutional Series A pace. The pitch should lead with revenue, gross margin, retention metrics, and a credible regional expansion plan. AI narrative should connect to specific commercial outcomes.

Caveats. The firm’s multi-stage flexibility means partner attention is concentrated on category leaders; founders without Series A scale should approach later. The healthcare-specific portfolio is real but participates in a broader thesis spanning fintech, commerce, and other digital economy categories; reference calls with health-sector founders are advisable. The check range is wide; clarify expected ownership and lead status early. For SEA or Indian Series A and Series B health-tech founders with credible regional ambitions, Jungle Ventures is among the strongest regional partners; for early-stage or US-only founders, the fit is weaker.